Provider
QP26-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2025
Program effective Date: Mar 12, 2025
Documents & Forms Results
Displaying 401 - 410 of 3159 results
Provider
QP25-25 MHCP Pharmacy Benefit Exclusion for Datroway®, Frindovyx™, Kebilidi™ and Niktimvo™
Program effective Date: Mar 12, 2025
Provider
QP24-25 Commercial Pharmacy Benefit Exclusion for Octreotide Kit, Sandostatin® Kit LAR, and Signifor® LAR injection
Program effective Date: Mar 12, 2025
Provider
QP23-25 Commercial Pharmacy Benefit Exclusion for Kebilidi™, Niktimvo™, Steqeyma® and Yesintek™
Program effective Date: Mar 12, 2025
Provider
QP22-25 Provider Press: Q1 2025
Program effective Date: Mar 12, 2025
Provider
QP29-25 Denials for Charges Denied based on Medicare NCD and LCD Policies
Program effective Date: Mar 12, 2025
Provider
QP28-25 REMINDER: Process Update for Post-Acute Care Authorizations managed by eviCore Healthcare
Program effective Date: Mar 12, 2025
Provider
QP21-25 Appropriate Use of Modifier -25
Program effective Date: Mar 12, 2025